Indapta Therapeutics Employee Directory
Biotechnology ResearchSeattle & Houston , United States11-50 Employees
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.